Anti-Proliferative Effects of Compound a and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells
BACKGROUND: Cholangiocarcinoma (CCA) is a fatal cancer with high resistance to anticancer drugs. The development of new drugs or compounds to be used alone or in combination with currently available chemotherapeutic agents to improve the treatment of CCA is needed. Compound A (CpdA), which is a sma...
محفوظ في:
المؤلفون الرئيسيون: | Mutita Junking, Thidarath Rattanaburee, Aussara Panya, Irina Budunova, Guy Haegeman, Pa Thai Yenchitsomanus |
---|---|
التنسيق: | دورية |
منشور في: |
2020
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85092062803&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70186 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
المؤسسة: | Chiang Mai University |
مواد مشابهة
-
Anti-proliferative effects of compound a and its effect in combination with Cisplatin in Cholangiocarcinoma Cells
بواسطة: Mutita Junking, وآخرون
منشور في: (2020) -
Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A
بواسطة: Thidarath Rattanaburee, وآخرون
منشور في: (2018) -
Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells
بواسطة: Chutamas Thepmalee, وآخرون
منشور في: (2018) -
Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells
بواسطة: Chutamas Thepmalee, وآخرون
منشور في: (2018) -
Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells
بواسطة: Chutamas Thepmalee, وآخرون
منشور في: (2019)